Mask usage is one of the most important precautions to limit the spread of COVID-19. Therefore, hygiene rules enforce the correct use of face coverings. Automated mask usage classification might be used to improve compliance monitoring. This study deals with the problem of inappropriate mask use. To address that problem, 2075 face mask usage images were collected. The individual images were labeled as either mask, no masked, or improper mask. Based on these labels, the following three cases were created: Case 1: mask versus no mask versus improper mask, Case 2: mask versus no mask + improper mask, and Case 3: mask versus no mask. This data was used to train and test a hybrid deep feature-based masked face classification model. The presented method comprises of three primary stages: (i) pre-trained ResNet101 and DenseNet201 were used as feature generators; each of these generators extracted 1000 features from an image; (ii) the most discriminative features were selected using an improved RelieF selector; and (iii) the chosen features were used to train and test a support vector machine classifier. That resulting model attained 95.95%, 97.49%, and 100.0% classification accuracy rates on Case 1, Case 2, and Case 3, respectively. Having achieved these high accuracy values indicates that the proposed model is fit for a practical trial to detect appropriate face mask use in real time.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871993 | PMC |
http://dx.doi.org/10.3390/ijerph19041939 | DOI Listing |
Toxicol Sci
January 2025
Department of Chemistry and Environmental Science, New Jersey Institute of Technology, Newark, NJ, 07103.
Phthalates are known endocrine disrupting chemicals and ovarian toxicants that are used widely in consumer products. Phthalates have been shown to exert ovarian toxicity on multiple endpoints, altering transcription of genes responsible for normal ovarian function. However, the molecular mechanisms by which phthalates act on the ovary are not well understood.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Background: In-vivo magnetic resonance imaging (MRI) has recently shown that patients with clinically diagnosed Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) exhibit degeneration of the cholinergic nucleus basalis of Meynert and its white matter (WM) projections through the cingulum and external capsule pathways. Here, we propose an imaging-pathologic validation study aimed at investigating cholinergic WM pathways using post-mortem MRI of autopsy-confirmed AD, Lewy body dementia (LBD), and other neurodegenerative diseases (OTH).
Method: We included 53 brain donors (34 AD, 10 LBD, and 9 OTH, mainly including frontotemporal lobe degeneration and vascular disease, Table 1).
Alzheimers Dement
December 2024
Stevens Neuroimaging and Informatics Institute, Los Angeles, CA, USA.
Background: Positron emission tomography (PET) tau tracer PI-2620 frequently shows off-target meningeal binding (Figure 1). Of standard regions of interest, only lateral parietal (LP) is contaminated by this. We compare the standardized uptake value ratio (SUVR) in the LP before and after eroding the LP mask to remove meningeal contamination.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Neuroscience Institute, NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.
Background: The entorhinal cortex and hippocampus are loci of early vulnerability in AD. These areas are crucial for episodic memory processing for space and contexts. The majority of AD model mouse imaging and electrode studies utilize simple tasks such open field and linear track.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Pittsburgh, Pittsburgh, PA, USA.
Background: Recent studies showed that neuroinflammation plays a key role in triggering specific neuropsychiatric symptoms (NPS), such as irritability and agitation, in individuals with Alzheimer's disease (AD). While prior studies showed an association between tau pathology and all NPS domains, the extent to which tau influences each specific NPS domain remains unclear. Here, we aim to investigate the association of tau and NPS domains in the AD continuum.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!